TOKYO, May 26 (Pulse News Wire) – Cuorips Inc. (4894.T) announced today that its board of directors decided to relocate its headquarters to Osaka, Osaka Shi Kita Ku Nakanoshima, effective upon approval during the upcoming extraordinary shareholders' meeting scheduled for May 26, 2026.
The relocation is contingent on shareholder approval at the meeting set for June 25, 2026. The move aims to strengthen activities and collaborations within the Kansai region, leveraging the company's advanced cell culture facilities and technologies to support the rapid and healthy development of regenerative medicine globally. The new location, situated inside Osaka Life Science Nexus by Nippon Life and CIC (O-Nexus), aligns closely with the company’s strategic goals. The official relocation date will be determined at a subsequent board meeting held by March 31, 2027.
According to the company, the impact on fiscal 2027 earnings is expected to be minor. Additionally, Cuorips plans to amend Article III of its articles of incorporation to reflect the new headquarters address. The amendment will take effect on the same day as the headquarters relocation and will be removed from the articles once the relocation becomes effective. The extraordinary shareholders’ meeting to vote on these changes is tentatively planned for June 25, 2026.
The amended articles will come into force on the relocation date, which will be finalized at a future board meeting by March 31, 2027.
🟡 Confidence: Standard AI-translated content.